Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology
@article{OBrien2017ClinicalPW, title={Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology}, author={J. O'Brien and C. Holmes and M. Jones and R. Jones and G. Livingston and I. McKeith and P. Mittler and P. Passmore and C. Ritchie and L. Robinson and E. Sampson and J. Taylor and A. Thomas and A. Burns}, journal={Journal of Psychopharmacology}, year={2017}, volume={31}, pages={147 - 168} }
The British Association for Psychopharmacology coordinated a meeting of experts to review and revise its previous 2011 guidelines for clinical practice with anti-dementia drugs. As before, levels of evidence were rated using accepted standards which were then translated into grades of recommendation A–D, with A having the strongest evidence base (from randomised controlled trials) and D the weakest (case studies or expert opinion). Current clinical diagnostic criteria for dementia have… CONTINUE READING
138 Citations
Anti-dementia medications: current prescriptions in clinical practice and new agents in progress
- Medicine
- Therapeutic advances in drug safety
- 2015
- 27
- PDF
Effects of pharmacological and nonpharmacological treatments on brain functional magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment: a critical review
- Medicine
- Alzheimer's Research & Therapy
- 2018
- 6
- Highly Influenced
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment
- Medicine
- Alzheimer's & dementia
- 2020
Efficacy of Cholinesterase Inhibitors in Vascular Dementia: An Updated Meta-Analysis
- Medicine
- European Neurology
- 2016
- 19
Adequacy of Using Consensus Guidelines for Diagnosis of Dementia with Lewy Bodies in Clinical Trials for Drug Development
- Medicine
- Dementia and Geriatric Cognitive Disorders
- 2015
- 5
Management of mild cognitive impairment (MCI): The need for national and international guidelines
- Medicine
- The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
- 2020
- 7
Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
- Medicine
- Journal of Alzheimer's disease : JAD
- 2019
- 3
Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs
- Medicine
- Expert opinion on pharmacotherapy
- 2019
- 6
- Highly Influenced
Guidelines for dementia or Parkinson’s disease with depression or anxiety: a systematic review
- Medicine
- BMC Neurology
- 2016
- 18
Treatment Options for Dementia with Lewy Bodies: A Network Meta-Analysis of Randomised Control Trials
- Medicine
- Neurology and Therapy
- 2020
- PDF
References
SHOWING 1-10 OF 271 REFERENCES
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
- Medicine
- Journal of psychopharmacology
- 2011
- 121
- PDF
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
- Medicine
- Journal of psychopharmacology
- 2006
- 145
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
- Medicine
- The Lancet Neurology
- 2009
- 383
- Highly Influential
- PDF
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline
- Medicine
- European journal of neurology
- 2007
- 574
- PDF
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.
- Psychology, Medicine
- Current Alzheimer research
- 2008
- 231
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
- Psychology, Medicine
- Journal of Neurology, Neurosurgery & Psychiatry
- 2014
- 141
Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study
- Psychology, Medicine
- International journal of geriatric psychiatry
- 2000
- 165
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials
- Medicine
- The Lancet Neurology
- 2007
- 327
Guidelines for the Treatment of Alzheimer’s Disease from the Italian Association of Psychogeriatrics
- Medicine
- Drugs & aging
- 2005
- 47
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
- Psychology, Medicine
- The Lancet Neurology
- 2010
- 324
- Highly Influential